GlaxoSmithKline | Biaya Penjualan

Harga Saham
2,198.00
Perubahan Harian
18.00 0.83%
Bulanan
15.59%
Tahunan
52.32%
Q1 Perkiraan
2,154.48




Biaya Penjualan Perubahan Tanggal
AbbVie USD 4.55B 757M 2025-12
Alcon AG USD 1.16B 52M 2025-09
Almirall EUR 193.79M 12.62M 2025-06
Amgen USD 1.79B 128M 2025-12
argenx SE USD 109.43M 1.32M 2025-09
AstraZeneca USD 2.8B 328M 2025-09
Bayer EUR 4.31B 57M 2025-09
Biogen USD 810.1M 205.1M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Fresenius EUR 4.19B 62M 2025-09
Fresenius Medical Care EUR 3.64B 65.63M 2025-09
Galapagos EUR 84.73M 80.02M 2025-09
Genmab DKK 57M 15M 2025-06
Gilead Sciences USD 1.57B 68M 2025-09
GlaxoSmithKline GBP 2.61B 377M 2025-12
Glaxosmithkline GBP 3.01B 853.01M 2025-09
GRIFOLS EUR 1.13B 15.63M 2025-09
Hikma Pharmaceutical USD 466.5M 428.5M 2025-06
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.1B 123M 2025-09
Merck USD 3.32B 531M 2025-12
Novartis USD 3.54B 217M 2025-09
Novo Nordisk DKK 15.15B 2.3B 2025-12
Orion EUR 169M 900K 2025-09
Pfizer USD 6.29B 2.12B 2025-12
Philips EUR 2.39B 65M 2025-09
Recordati EUR 199.91M 20.12M 2025-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 4.29B 421M 2025-12
Smith & Nephew USD 870M 17M 2025-12
UCB EUR 901M 50M 2024-12


GlaxoSmithKline Biaya Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.